Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit

Critical Care Medicine

Volumn 24, Issue 10, 1996, Pages 1749-1756

  Rudis, Maria I ^a   Guslits, Benjamin J ^a   Peterson, Edward L ^a   Hathaway, Stephen J ^a   Angus, Elizabeth ^a   Beis, Sara ^a   Zarowitz, Barbara J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

critical illness; critically ill; electromyography; motor neuropathy; neurology; neuromuscular blockade; nondepolarizing neuromuscular blockers; outcome; pancuronium; vecuronium

Indexed keywords

AMINOGLYCOSIDE; CORTICOSTEROID; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; VECURONIUM;

ACCOUNTING; ADULT; AGED; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL BED; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL RECORD; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HOSPITAL CHARGES; HOSPITAL COSTS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKADE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029860082     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199610000-00024     Document Type: Review

References (29)

1. Op de Coul AAW, Lambregts PCLA, Kroeman J, et al: Neuromuscular complications in patients given Pavulon® (pancuronium bromide) during mechanical ventilation. Clin Neurol Neurosurg 1980; 87:17-22
2. MacFarlane IA, Rosenthal FD: Severe myopathy after status asthmaticus. Lancet 1977; ii:615
3. Gooch JL, Suchyta MR, Balbierz JM, et al: Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991; 19: 1125-1131
4. Kupfer Y, Okrent DG, Twersky RA, et al: Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade. Crit Care Med 1987; 15:795-796
5. Hirano M, Ott BR, Raps EC, et al: Acute quadriplegic myopathy: A complication of treatment with steroids, non-depolarizing blocking agents, or both. Neurology 1992; 42:2082-2087
6. Danon MJ, Carpenter S: Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991; 14:1131-1139
7. Haas JL, Shaefer MS, Miwa LJ, et al: Prolonged paralysis associated with long-term pancuronium use. Pharmacotherapy 1989; 9:154-157
8. Kupfer Y, Namba T, Kaldawi E, et al: Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med 1992; 117:484-486
9. Barohn RJ, Jackson CE, Rogers SJ, et al: Prolonged paralysis due to non-depolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17:647-654
10. Gorson KC, Ropper AH: Acute respiratory failure neuropathy: A variant of critical illness polyneuropathy. Crit Care Med 1993; 21:267-271
11. Aggarwal A, Gutmann L, Gutierrez A: Electrophysiological features of vecuronium induced prolonged neuromuscular blockade. Muscle Nerve 1994; 17: 251-252
12. Manthous CA, Chatila W: Prolonged weakness after the withdrawal of atracurium. Am J Respir Crit Care Med 1994; 150:1441-1443
13. Watling SM, Dasta JF: Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature. Crit Care Med 1994; 22:884-893
14. Segredo V, Caldwell JE, Matthay MS, et al: Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327:524-528
15. Raps EC, Bird SJ, Hansen-Flaschen J: Prolonged muscle weakness after neuromuscular blockade in the intensive care unit. Crit Care Clin 1994; 10: 799-812
16. Gooch JL: AHEM case report # 29: Prolonged paralysis after neuromuscular blockade. Muscle Nerve 1995; 18: 937-942
17. Zochodne DW, Ramsay DA, Saly V, et al: Acute necrotizing myopathy of intensive care: Electrophysiologic studies. Muscle Nerve 1994; 17:285-292
18. Ramsay DA, Zochodne DW, Robertson DM, et al: A syndrome of acute severe muscle necrosis intensive care unit patients. J Neuropathol Exp Neurol 1993; 52:387-398
19. Lacomis D, Smith TW, Chad DA: Acute myopathy and neuropathy in status asthmaticus: Case report and literature review. Muscle Nerve 1993; 16:84-90
20. Waclawik AJ, Sufit RL, Beinlich BR, et al: Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium. Neuromuscul Disord 1992; 2:19-26
21. Douglass J, Tuxen M, Horne C, et al: Acute myopathy following treatment of severe life threatening asthma. Abstr. Am Rev Respir Dis 1990; 141:A397
22. Witt NJ, Zochodne DW, Bolton CP, et al: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99:176-184
23. Spitzer AR, Giancarlo T, Maher L, et al: Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve 1992; 15:682-686
24. Coakley JH, Nagendran K, Honavar M, et al: Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993; 19:323-328
25. Hansen-Flaschen JH, Cowen J, Raps EC: Neuromuscular blockade in the intensive care unit. More than what we bargained for. Am Rev Respir Dis 1993; 147:234
26. Cleverley WO: Essentials of Health Care Finance. Third Edition. Gaithersburg, MD, Aspen Publishers, 1992
27. Hollander M, Wolfe DA: Nonparametric statistical methods. New York, Wiley, 1973, pp 75-81
28. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
29. Devine BJ: Gentamicin therapy. Drug Intell Clin Pharm 1974; 8:650-655